John K Chan, M.D.
Investigator
Clinical trials
- Clinical trial
Adjuvant Endometrial Cancer GCT1184-03
A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy
Status: Open to Enrollment
- Clinical trial
Neoadjuvant Gynecological Cancers CORT125134-557 BELLA
An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers (BELLA)
Status: Open to Enrollment